[KLK] QoQ Cumulative Quarter Result on 30-Sep-2012 [#4]

Stock
[KLK] KUALA LUMPUR KEPONG BHD
Announcement Date
21-Nov-2012
Admission Sponsor
-
Sponsor
-
Financial Year
30-Sep-2012
Quarter
30-Sep-2012 [#4]
Profit Trend
QoQ- 53.52%
YoY- -22.92%
Quarter Report
Latest QR
Upcoming QR
KLK's Result
KLK's Financial Summary
View:
Show?
Cumulative Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 6,732,525 4,556,507 2,320,957 10,570,188 8,150,560 5,547,381 2,923,177 74.48%
PBT 867,060 638,170 353,610 1,560,436 1,087,666 774,807 463,205 51.94%
Tax -170,505 -140,364 -81,291 -300,347 -257,915 -186,359 -105,395 37.84%
NP 696,555 497,806 272,319 1,260,089 829,751 588,448 357,810 55.97%
-
NP to SH 659,738 470,576 260,919 1,211,244 788,978 555,893 340,985 55.33%
-
Tax Rate 19.66% 21.99% 22.99% 19.25% 23.71% 24.05% 22.75% -
Total Cost 6,035,970 4,058,701 2,048,638 9,310,099 7,320,809 4,958,933 2,565,367 76.99%
-
Net Worth 7,156,569 7,188,518 7,454,759 7,113,970 6,783,831 7,007,233 7,348,263 -1.74%
Dividend
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Div 159,744 159,744 - 692,227 159,744 159,739 - -
Div Payout % 24.21% 33.95% - 57.15% 20.25% 28.74% - -
Equity
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Net Worth 7,156,569 7,188,518 7,454,759 7,113,970 6,783,831 7,007,233 7,348,263 -1.74%
NOSH 1,064,965 1,064,965 1,064,965 1,064,965 1,064,965 1,064,929 1,064,965 0.00%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin 10.35% 10.93% 11.73% 11.92% 10.18% 10.61% 12.24% -
ROE 9.22% 6.55% 3.50% 17.03% 11.63% 7.93% 4.64% -
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
RPS 632.18 427.85 217.94 992.54 765.34 520.92 274.49 74.48%
EPS 61.90 44.20 24.50 113.74 74.08 52.20 32.02 55.24%
DPS 15.00 15.00 0.00 65.00 15.00 15.00 0.00 -
NAPS 6.72 6.75 7.00 6.68 6.37 6.58 6.90 -1.74%
Adjusted Per Share Value based on latest NOSH - 1,064,965
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
RPS 597.03 404.07 205.82 937.35 722.78 491.93 259.22 74.49%
EPS 58.50 41.73 23.14 107.41 69.97 49.30 30.24 55.31%
DPS 14.17 14.17 0.00 61.39 14.17 14.17 0.00 -
NAPS 6.3464 6.3747 6.6108 6.3086 6.0158 6.2139 6.5163 -1.74%
Price Multiplier on Financial Quarter End Date
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Date 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 -
Price 21.72 20.92 24.00 22.06 22.94 24.60 22.70 -
P/RPS 3.44 4.89 11.01 2.22 3.00 4.72 8.27 -44.30%
P/EPS 35.06 47.34 97.96 19.40 30.96 47.13 70.90 -37.49%
EY 2.85 2.11 1.02 5.16 3.23 2.12 1.41 59.93%
DY 0.69 0.72 0.00 2.95 0.65 0.61 0.00 -
P/NAPS 3.23 3.10 3.43 3.30 3.60 3.74 3.29 -1.22%
Price Multiplier on Announcement Date
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Date 20/08/13 22/05/13 20/02/13 21/11/12 29/08/12 24/05/12 22/02/12 -
Price 21.24 21.70 21.32 20.56 23.24 22.16 23.64 -
P/RPS 3.36 5.07 9.78 2.07 3.04 4.25 8.61 -46.62%
P/EPS 34.29 49.11 87.02 18.08 31.37 42.45 73.83 -40.05%
EY 2.92 2.04 1.15 5.53 3.19 2.36 1.35 67.32%
DY 0.71 0.69 0.00 3.16 0.65 0.68 0.00 -
P/NAPS 3.16 3.21 3.05 3.08 3.65 3.37 3.43 -5.32%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment